Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03
+4.110.60%
Number of Gainers:71
Number of Losers:69
Number of Flat:14
PE:- -
High:698.21
Open:689.82
Low:685.07
Close:688.92
Volume:272.16M
Turnover:8.90B
Market Cap:479.85B
Float Cap:365.12B

Loading ...

Kaltura Officer Azaria Eynav Disposes of USD 18,534 in Common Shares

Reuters
·
Sep 03

Climb Bio price target raised to $40 from $23 at Piper Sandler

TIPRANKS
·
Sep 03

Robinhood Markets up over 12%, on Track for Highest Close Since January

Dow Jones
·
Sep 03

Global-E President Debbi Nir Sells 8,332 Shares for $310,200

Reuters
·
Sep 03

NASDAQ Trade Halt Volatility Trading Pause at 09:30 Am

Reuters
·
Sep 03

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Volaris Reports August 2026 Traffic Results: Load Factor of 84%

GlobeNewswire
·
Sep 03

Zhihu Sets Up 15 Billion Yuan Subsidiary, Shifting AI Strategy from Products to a Dedicated Business Entity

Deep News
·
Sep 03

Kaltura Partners with Verimatrix to Bolster Security for OTT, Cloud TV Services

Reuters
·
Sep 03

Mobix Labs Lands Repeat Gulfstream Order for 1,500 Aircraft Components

Reuters
·
Sep 03

Mobix Labs Secures 1,500-Component Gulfstream Production Order

THOMSON REUTERS
·
Sep 03

Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Quince Therapeutics to Participate in September 2026 Investor Conferences

GlobeNewswire
·
Sep 03

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Biomea Fusion to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Climb Bio Reports Early Phase 1 Data for IgA Nephropathy Drug

MT Newswires Live
·
Sep 03

Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan

Dow Jones
·
Sep 03

Climb Bio - Announces Positive Phase 1 Data for Clym116 in Iga Nephropathy

THOMSON REUTERS
·
Sep 03

Climb Bio - Phase 2 Navigate-2 Trial Ongoing; Initial Data Expected H1 2027, Phase 3 Initiation in 2027

THOMSON REUTERS
·
Sep 03